Methotrexate (Methotrexate)



Indications and Reactions:

Role Indications Reactions
Primary
Rheumatoid Arthritis 60.0%
Abortion Induced 8.0%
Juvenile Idiopathic Arthritis 8.0%
Arthritis 4.0%
B Precursor Type Acute Leukaemia 4.0%
B-cell Lymphoma 4.0%
Diffuse Large B-cell Lymphoma 4.0%
Polyarthritis 4.0%
Sedative Therapy 4.0%
Anaemia 6.7%
Bronchial Carcinoma 6.7%
Hepatitis B 6.7%
Hypersensitivity 6.7%
Mucosal Inflammation 6.7%
Mycobacterial Infection 6.7%
Nasal Congestion 6.7%
Necrotising Fasciitis 6.7%
Nephropathy Toxic 6.7%
Pneumonia 6.7%
Staphylococcal Sepsis 6.7%
Syndactyly 6.7%
Tonsil Cancer 6.7%
Toxicity To Various Agents 6.7%
Vomiting 6.7%
Secondary
Acute Lymphocytic Leukaemia 20.4%
Product Used For Unknown Indication 12.7%
Rheumatoid Arthritis 9.4%
Primitive Neuroectodermal Tumour 6.6%
Burkitt's Lymphoma 5.5%
Malignant Lymphoid Neoplasm 5.5%
Lymphoblastic Lymphoma 4.4%
Aesthesioneuroblastoma 3.9%
Bone Sarcoma 3.9%
Diffuse Large B-cell Lymphoma 3.3%
Osteosarcoma Metastatic 3.3%
Gestational Trophoblastic Tumour 2.8%
Malignant Hydatidiform Mole 2.8%
Metastatic Choriocarcinoma 2.8%
Osteomyelitis Bacterial 2.8%
Takayasu's Arteritis 2.8%
Juvenile Idiopathic Arthritis 2.2%
Chemotherapy 1.7%
Ill-defined Disorder 1.7%
Immunosuppressant Drug Therapy 1.7%
Rash 8.0%
Sepsis 8.0%
Walking Aid User 8.0%
Weight Decreased 8.0%
White Blood Cell Count Decreased 8.0%
Acute Myeloid Leukaemia 4.0%
Cholangiocarcinoma 4.0%
Completed Suicide 4.0%
Hepatitis B Dna Increased 4.0%
High Density Lipoprotein Decreased 4.0%
Hypertension 4.0%
Hypothyroidism 4.0%
Metastases To Peritoneum 4.0%
Mucosal Inflammation 4.0%
Multi-organ Failure 4.0%
Nephropathy Toxic 4.0%
Neurotoxicity 4.0%
Neutropenic Sepsis 4.0%
No Therapeutic Response 4.0%
Overdose 4.0%
Concomitant
Bone Marrow Conditioning Regimen 12.7%
Rheumatoid Arthritis 12.7%
Product Used For Unknown Indication 11.8%
Acute Lymphocytic Leukaemia 9.8%
Osteoporosis 6.9%
Systemic Lupus Erythematosus 6.9%
Immunodeficiency Common Variable 4.9%
Juvenile Idiopathic Arthritis 3.9%
Acute Myeloid Leukaemia 2.9%
Hepatitis C 2.9%
Multiple Sclerosis 2.9%
Osteoporosis Prophylaxis 2.9%
Psoriasis 2.9%
Therapeutic Procedure 2.9%
Thrombosis Prophylaxis 2.9%
Drug Use For Unknown Indication 2.0%
Actinic Keratosis 2.0%
Cellulitis 2.0%
Depression 2.0%
Non-hodgkin's Lymphoma 2.0%
Urinary Tract Infection 10.9%
Stress Fracture 8.7%
Vomiting 8.7%
Hypersensitivity 6.5%
Nausea 6.5%
Thrombosis 6.5%
Acute Graft Versus Host Disease 4.3%
Rheumatoid Arthritis 4.3%
Septic Shock 4.3%
Spinal Column Stenosis 4.3%
Syncope 4.3%
Thrombocytopenia 4.3%
Treatment Failure 4.3%
Vision Blurred 4.3%
Visual Impairment 4.3%
Weight Decreased 4.3%
Acute Generalised Exanthematous Pustulosis 2.2%
Adenovirus Infection 2.2%
Application Site Discolouration 2.2%
Application Site Erythema 2.2%